Jun 2026· IEEE transactions on computational biology and bioinformatics· Vol PP· 0 citations
Medicine
Abstract
Identifying gene-disease associations (GDAs) remains a fundamental challenge in biomedical research due to the enormous combinatorial space of candidate gene-disease pairs and the limited scalability of experimental validation. As wet lab studies cannot keep pace with rapidly expanding omics data, computational approaches have become essential for prioritizing plausible GDAs and accelerating biological discovery. Recent advances in artificial intelligence (AI), particularly graph neural networks (GNNs) and large language models (LLMs), are trans forming this field by enabling richer biological representations and more accurate predictive modeling. In this survey, we provide a unified and up-to-date overview of AI-driven GDA prediction. We first summarize major public resources containing gene, dis ease, and auxiliary biological information that underpin computational studies. We then review methodological developments ranging from traditional network-based methods to machine learning, deep learning, and the emerging integration of GNNs and LLMs, which has received limited attention in previous GDA-focused surveys. Representative applications in gene prioritization, drug repurposing, and clinical research are also discussed to demonstrate the practical impact of these approaches. Finally, we outline current challenges and promising future directions. By integrating data resources, methodological advances, and translational applications, this survey provides a comprehensive overview of modern AI techniques for GDA prediction and aims to support the development of more robust, interpretable, and clinically actionable computational tools. All curated resources and re viewed literature are publicly available in our GitHub repository (last updated September 2025; including peer-reviewed publications and preprints on AI-driven GDA prediction published through September 2025): https://github.com/linyaoyang/gene disease-association-prediction-papers.
MMAG is proposed, a novel framework that formulates miRNA–disease association prediction as a meta-conditional distribution alignment problem on multi-scale biological graphs and offers a promising strategy for broader biological network inference tasks.
Zhang Yu, Zuo Xuan, Tang Ying et al.· Frontiers in Bioinformatics· 0 citations
This review describes the main characteristics and limitations of standard statistical approaches for GWAS, the main uses of AI methods in computational genomics, and recent attempts to leverage AI strategies in GWAS and presents 30 methods designed to leverage AI in GWAS.
S. D’Antona, Mawada Elmagboul Abdalla Abakar, Daniele Ramazzotti et al.· BioData Mining· 0 citations
This review systematically analyzes the emerging landscape of FMs in omics research, spanning sequence modeling, cell state characterization, and multimodal integration, and proposes a roadmap for the next generation of FMs, advocating for architectures that move beyond statistical correlation to incorporate causal reasoning, temporal dynamics, and autonomous experimental validation.
Haozhe Liu, Wenhao Cai, Yizheng Sun et al.· Briefings in Bioinformatics· 0 citations
This review provides a comprehensive pipeline for artificial intelligence/machine learning in cancer research, including preclinical research, clinical decision support, and real-world implementation, and critically examines multi-omics fusion architectures, regularization-based machine learning, batch-effect harmonization, explainable AI, and federated learning.
Shalini Saha, Md Saif Ali, A. Tengli et al.· Journal of Translational Med...· 0 citations
A clinically oriented, pipeline-based synthesis of contemporary AI applications in genomic medicine, focusing on factors that determine model robustness and clinical utility, and common sources of failure in real-world genomic AI systems.
Alexandra-Maria Blaga, Răzvan-Octavian Mihuț, A. Treteanu et al.· International Journal of Mol...· 0 citations
Recent literature on the application of artificial intelligence (AI) and data science within bioinformatics-driven cancer drug discovery is synthesized, examining how these tools are reshaping target identification, molecular design, biomarker discovery, and treatment personalization.
Yejide Eniola Dabiri· Magna Scientia Advanced Rese...· 0 citations